Could rituximab be a silver lining in refractory bone marrow fibrosis caused by lupus?

[...]it induces cell death, cytopenia, and myelosuppression.1 Most cytopenias in the SLE period resolve with disease control. [...]line treatment with intravenous immunoglobulin has demonstrated clinically meaningful results.9 Other potential agents for SLE-associated myelofibrosis include azathiopr...

Full description

Saved in:
Bibliographic Details
Published inArchives of rheumatology Vol. 39; no. 3; pp. 476 - 478
Main Authors Bulut Gökten, Dilara, Yümün Kavak, Fatma, Mercan, Rıdvan
Format Journal Article
LanguageEnglish
Published Istanbul Prof Sebnem Ataman, President Turkish League Against Rheumatism 01.09.2024
Subjects
Anemia
Antibodies
Authorship
Autoimmune diseases
Blood
Blood platelets
Bone marrow
Case reports
Conflicts of interest
Cytotoxicity
Disease
Hemoglobin
Immunoglobulins
Leukocytes
Literature reviews
Lupus
Lymphocytes
Neutrophils
Patients
Remission (Medicine)
Online AccessGet full text

Cover

More Information
Summary:[...]it induces cell death, cytopenia, and myelosuppression.1 Most cytopenias in the SLE period resolve with disease control. [...]line treatment with intravenous immunoglobulin has demonstrated clinically meaningful results.9 Other potential agents for SLE-associated myelofibrosis include azathioprine, mycophenolate mofetil, and cyclosporine. [...]the patient was diagnosed with SLE, and treatment was started. [...]we initiated off-label treatment with rituximab. D.B.G., R.M.; Materials: F.Y.K. Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
ISSN:2148-5046
1309-0291
2618-6500
1309-0283
DOI:10.46497/ArchRheumatol.2024.10564